Open Access

ARTICLE

Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-κB/p65 activation in cutaneous squamous cell carcinoma

ZHIXUN XIAO¹, QIUYUN XU¹, HAIQING WANG¹, XIAOTONG ZHOU², YANTING ZHU¹, CHENGBEI BAO¹, LIHONG CHEN¹, PENG ZHANG¹, MIN LIN¹, CHAO JI^1,*, TING GONG^3,*

1 Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China
2 Cancer Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China
3 Central Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China

* Corresponding Authors: Chao Ji, ; Ting Gong,

Oncology Research 2023, 31(1), 71-82. https://doi.org/10.32604/or.2022.028075

Received 30 November 2022; Accepted 19 January 2023; Issue published 01 March 2023

Abstract

Cutaneous squamous cell carcinoma (cSCC), a type of non-melanoma skin cancer (NMSC), is the most common malignancy worldwide. Thioredoxin (TXN) domain-containing protein 9 (TXNDC9) is a member of the TXN family that is important in cell differentiation. However, the biological function of this protein in cancer, particularly cSCC, is still unknown. In the present study, our experiments revealed the protective effects of TXNDC9 on UV-B-irritated cSCC cells. The initial findings showed that TXNDC9 is significantly upregulated in cSCC tissue and cells compared to normal skin tissue and keratinocytes. UV-B radiation robustly induces the expression of TXNDC9, and UV-B-induced cSCC cell death is boosted by TXNDC9 deficiency. Moreover, cSCC cells lacking TXNDC9 displayed attenuated activation of the NF-κB pathway. Additional studies by inhibiting TXNDC9 confirmed this finding, as TXNDC9 deficiency attenuated UV-B radiation-induced translocation of NF-κB p65 from the cytoplasm to the nucleus of cSCC. In conclusion, our work demonstrates the biological roles of TXNDC9 in cSCC progression and may provide a novel therapeutic target to treat cSCC in the future.

---

Keywords

---